Article
SOD2 genetic polymorphism (rs4880) has no impact on 6-month response to antidepressant treatment and inflammatory biomarkers in depressed patients.
Basic & clinical pharmacology & toxicology - 1 Mar 2020
Ait Tayeb Abd El Kader, Becquemont Laurent, El-Asmar Khalil, Mahmoudi Kaïna, Colle Romain, Trabado Severine, Gressier Florence, Feve Bruno, Corruble Emmanuelle, Verstuyft Céline
Abstract excerpt
Two thirds of patients suffering from a major depressive episode (MDE) do not reach a complete response with antidepressant drugs. This lack of response is due to several factors, including genetic determinants. Since major depressive disorder is associated with inflammatory and oxidative stress abnormalities, the metabolism of superoxide anions might be involved in non-response to antidepressant drugs....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
